ArticleMolecular cancer therapeutics2018

Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.

Jeremy Karlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.